Product/Service

YpsoDot – The Fixed-Dose Pen Delivering Up To 1 mL

Source: Ypsomed
Ypsodot

See how fixed-dose flexibility, simplified handling, multi-use functionality, and sustainability considerations can address emerging needs in self-injection.

YpsoDot is a fixed-dose, pull-and-push pen supporting patients with a clear, confirmed sequence designed to facilitate correct use from the first injection.

1 mL maximum fixed dose per injection

3-15 injections per pen, depending on dose configuration

Simplicity by design

A simplified device profile can help differentiate a therapy by reducing user burden and supporting intuitive self-injection. These advantages can make treatment easier to integrate into everyday life and potentially support adherence. As payers place greater emphasis on adherence and patient outcomes, device simplicity can also contribute to the value proposition of a therapy and support commercial differentiation.

  • Simple steps for fixed-dose injection sequence: pull & push
  • Pull-to-load mechanism designed to remove dose dialing from the patient interaction
  • Active dose-stop designed to improve dose accuracy
  • Visual and tactile confirmation cues at both load and inject steps​
  • No priming step, simplifying handling – no priming dose required

Fixed-dose deliveryup to 1.0 mL

Next-generation therapies are pushing beyond what conventional pens can deliver, in dose volume and in formulation complexity. Selecting the right delivery platform is not just a procurement choice; it establishes the foundation for your product’s entire commercial lifecycle. This is a strategic decision that impacts long-term success.

  • Fixed-dose range 0.2-1.0 mL, covering the next-gen biologics dose spectrum
  • Supports high-viscosity biologics beyond standard aqueous formulations
  • Pre-filled: no patient cartridge handling or loading
  • Platform architecture enables dose variants across the therapy lifecycle without device redesign

Multi-use cartridge, mono-material constructionDesigned with circularity in mind

Disposable injectors generate substantial single-use plastic waste. YpsoDot addresses this in two ways – responding to growing expectations related to carbon and resource reduction.

  • Mono-material construction: single polymer stream, designed to simplify end-of-life processing1
  • Bio-circular plastics, designed to reduce reliance on fossil-derived polymer1
  • Multi-use cartridge: one YpsoDot offers the option to may replace multiple disposable devices per monthly regimen, depending on dose configuration1
  • Lower CO₂-equivalent per injection vs. comparator devices1,2

  1. For details on product carbon footprint, bio-circular plastics and other sustainability-related information, please visit: www.ypsomed.com/sustainability-services
  2. Our life cycle assessment (LCA), conducted in September 2026 indicates a lower carbon footprint for YpsoDot (vs FixPen long cap) within the assessed scope, assumptions and system boundaries. Third party review pending (as of September 2026).
  3. 3 mL cartridge inner diameter of 9.7 mm recommended
  4. Dose configurations between 0.2-1 mL are possible (e.g. 0.75 mL)
  5. Pen needles according to ISO 11608-2